top of page

VisiCELL Competes for $10K in the BioTools Innovator Best Video Competition

  • johnnyakers
  • Sep 25
  • 2 min read
ree

We’re thrilled to share that VisiCELL is a proud participant in the 2025 BioTools Innovator cohort—a program that highlights groundbreaking technologies driving the future of life sciences.


As part of the program, we entered the Best Video Competition, where companies are challenged to tell their story in just one minute. The stakes are high: the winner will receive $10,000 to accelerate innovation, and the outcome is decided by community support. Every YouTube like counts as a vote.



Unlocking the Mystery of Cell Therapy

Cell therapies like CAR T, NK cells, TILs, and stem cells hold tremendous promise for treating cancer and other serious diseases. Yet one of the biggest challenges is visibility—once cells are delivered to the patient, it’s difficult to know where they go, how long they persist, and whether they reach the right targets.


That’s where VisiCELL comes in. Using MRI, we enable researchers and clinicians to track therapeutic cells in real time, providing critical insights into biodistribution, persistence, and engraftment. This level of visibility is key to:

  • Designing safer and more effective therapies

  • Reducing uncertainty in development

  • Enabling faster, smaller, and more insightful clinical trials


By making the invisible visible, VisiCELL helps accelerate the path from discovery to patient impact.


Why Your Vote Matters

Competitions like the BioTools Innovator Best Video Contest are more than just awards—they help amplify innovations that can shape the future of medicine.


For us, winning isn’t just about the $10,000 prize; it’s about gaining visibility, building momentum, and accelerating our mission to make next-generation cell therapies safer and more effective.


Your support makes a difference. By watching, liking, and sharing our video, you’re not only helping VisiCELL in this competition—you’re helping bring us closer to a future where patients can access cell therapies that are developed faster, smarter, and with greater confidence in their safety and effectiveness.




Join the Conversation

We’d love to hear your thoughts and connect with others passionate about advancing cell therapy. You can also help us spread the word by sharing our announcement on LinkedIn:




Together, we can amplify innovation and accelerate progress for patients.

Thank you for being part of this journey with us!



-Visicell Medical Team


 
 
 

Comments


bottom of page